endpts.com·Apr 17, 2026
Trevi Therapeutics plans to raise $150 million by selling over 11.5 million shares at $13 each.
For a professional interested in biotech and investment signals, Trevi Therapeutics' decision to sell $150 million in shares at $13 each indicates a significant fundraising effort that could bolster their development pipeline. This move might be worth monitoring for potential partnerships or advancements in their clinical trials that could impact the biotech market.